Abstract:
In our investigation we studied the influence of Tranexam on treatment of subchorionic hematomas in the background of gestational endotheliopathy. It was determined, that the usage of Tranexam, in the first trimester of pregnancy, among women with subchorionic hematomas in the background of gestational endotheliopathy, had accelerated regression and resorption of hematomas, had prolonged of pregnancy and had reduced of the percentage perinatal pathology compared with etamsylate.